Using MRD to guide post-alloSCT treatment decisions in AML

The importance of using MRD to guide treatment decisions in ALLПодробнее

Using MRD to Guide Therapy in AMLПодробнее

Using MRD to guide treatment decisions in the clinicПодробнее

Indications for allogeneic stem cell transplantation in AMLПодробнее

The benefit of using MRD to guide treatment decisions in multiple myelomaПодробнее

Should pre-transplant MRD be used to guide treatment in AML?Подробнее

How MRD assessment can inform treatment decisions in AMLПодробнее

Implementing MRD in clinical practice for patients with intermediate-risk AMLПодробнее

How can MRD guide treatment of AML?Подробнее

How does MRD guide therapeutic decisions in ALL?Подробнее

An insight into MRD monitoring and MRD-driven treatment in AMLПодробнее

The prognostic and therapeutic implications of MRD in AMLПодробнее

Methods to evaluate MRD in AMLПодробнее

Optimising transplant outcome in adults allografted for AMLПодробнее

The role of MRD in AML regulatory decision makingПодробнее

MRD as a monitoring technique of alloSCT and CAR-T in AML/ALLПодробнее

MRD in AML: prognoses, transplant and treatment planningПодробнее

Integrating genomics and MRD in transplant decision-making for patients with AMLПодробнее

The possibility of using MRD status to drive treatment in AMLПодробнее